Search alternatives:
decrease » decreased (Expand Search), increase (Expand Search)
Showing 61 - 80 results of 147 for search '(((( 50 pp decrease ) OR ( 50 a decrease ))) OR ((( 5 mg decrease ) OR ( 50 ng decrease ))))', query time: 0.12s Refine Results
  1. 61

    10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes by Goran Petrovski (129836)

    Published 2020
    “…The mean HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at the end of the study (p = 0.017). …”
  2. 62

    Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-... by Mohamed Yassin (4166515)

    Published 2025
    “…In the SUSTAIN study, a 5-mg/kg dose of crizanlizumab reduced the occurrence of vaso-occlusive crises (VOCs) and hospitalizations by 45 % and 41 %, respectively. …”
  3. 63

    Biodegradable polysaccharide grafted polyacrylamide inhibitor for corrosion in CO<sub>2</sub>- saturated saline solution by Rem Jalab (11715205)

    Published 2023
    “…Lastly, potentiostatic testing of steel with AGGPAM at an applied potential of 50 mV illustrated surface protection and decreased current over a prolonged time. …”
  4. 64

    Investigation of the Sustainable Production and Utilization of Biochar and Activated Carbon From Waste by Farah Yousef Taher Obar (19938288)

    Published 2023
    “…Out of the activated biochars tested, those produced without catalyst at 600 °C using either 2M KOH or 2% H<sub>3</sub>PO<sub>4</sub> at a ratio of 1:1 of SCG were found to be the most efficient adsorbents with a BET surface area greater than 340 m<sup>2</sup> .g<sup>-1</sup>, zeta potential of more than -75 mV and fixed carbon of 65%. Results of this study indicated that the biochar yield can increase with activation but decrease with increasing pyrolysis temperature and with increased concentration of both activating agent and catalyst. …”
  5. 65

    Exploring Beyond Numeric Weight Loss: The Metabolic Effects of Semaglutide. by Sara, Sokary

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7%, 0.5mg dose lowered HbA1c by 1.2–1.5%, while the 1.0 mg dose reduced it by 1.4–1.8%. …”
    Get full text
    Get full text
    Get full text
    article
  6. 66

    Endocrine contribution to the sexual dysfunction in patients with advanced chronic kidney disease and the role of hyperprolactinemia by Haitham Elbardisi (14058048)

    Published 2021
    “…Patients with hyperprolactinemia received treatment with cabergoline 0.5 mg once per week for 6 months and were re-evaluated. …”
  7. 67

    Synthetic Cannabinoid AB-FUBINACA Negatively Impacted the Male Fertility and Induced Testicular Toxicity by Ayman Alzu’bi (13162392)

    Published 2025
    “…AB-FUBINACA treatment also causes a significant dose related decrease in sperm viability. These findings were associated with higher level of oxidative stress (GP91 expression and malondialdehyde level) and elevated expression of key regulators of apoptosis (Bax and caspase-3) as well as reduced expression of mitochondrial respiratory chain complexes SDHB (II), UQCRC2 (III), and ATP5a (V) in the testicular tissue.…”
  8. 68

    One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes by Goran Petrovski (129836)

    Published 2022
    “…HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline, to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at 3 months (p = 0.02) and remained stable to 7.1 ± 0.6 (54 ± 6.6 mmol/mol) at 12 months (p = 0.02). …”
  9. 69

    Exploring beyond numeric weight loss: The metabolic effects of semaglutide by Sara Sokary (17337724)

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7 %, 0.5 mg dose lowered HbA1c by 1.2–1.5 %, while the 1.0 mg dose reduced it by 1.4–1.8 %. …”
  10. 70

    Enhanced oil recovery using hyperbranched polyglycerol polymer-coated silica nanoparticles by Wamda Faisal Elmobarak (17058024)

    Published 2021
    “…A D<sub>PSiMNPs</sub> = 100 mg/L was sufficient to achieve %η<sub>dem</sub> of 99.4% for C<sub>oil</sub> = 100 mg/L and slightly decreased to ~93% for C<sub>oil</sub> ~4000 mg/L. …”
  11. 71

    Interleukin-35 and Thymoquinone nanoparticle-based intervention for liver protection against paracetamol-induced liver injury in rats by Maisa Siddiq Abduh (16381125)

    Published 2023
    “…Group IV (PAR) received 600 mg/kg of PAR orally; V (PAR + IL-35) and VI (PAR + TYHO); rats received 600 mg/kg of PAR orally and i.p injection of IL-35 (200 ng/kg) or THYO (0.5 mg/kg), respectively. …”
  12. 72

    Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines by Najlah, Mohammad

    Published 2016
    “…Clinoleic loaded with paclitaxel decreased the viability of U87-MG cell to 6.4±2.3%, compared to Intralipid loaded with paclitaxel (21.29±3.82%). …”
    Get full text
    Get full text
    Get full text
    article
  13. 73

    Impact of severe hypoglycemia on the heat shock and related protein response by Alexander S. Atkin (18520107)

    Published 2021
    “…Proteomic analysis of heat shock-related and pro-inflammatory proteins was performed. At baseline, MAPKAPK5 (p = 0.02) and UBE2G2 (p = 0.003) were elevated and STUB1 decreased (p = 0.007) in T2D. …”
  14. 74

    Anabolic steroids-induced delirium by Mohamed Adil Shah Khoodoruth (14589828)

    Published 2020
    “…He was discharged on haloperidol 7.5 mg and quetiapine 700 mg daily.</p><h3>Conclusion</h3><p dir="ltr">The purpose of this case report is to emphasize on the neuropsychiatric effects and management of anabolic steroids manifested by delirium, increased aggression, hostility, and destructive impulses.…”
  15. 75

    The Impact of COVID-19 on the HIV Cascade of Care in Botswana – An Interrupted Time Series by Alice Sehurutshi (21842696)

    Published 2024
    “…In multivariable Poisson interrupted time series regression, the COVID-19 lockdown was associated with a 27% decrease in the monthly numbers of HIV tests (IRR 0.73, 95%CI 0.72–0.73), a 25% decrease in HIV positive tests (IRR 0.75, 95%CI 0.71–0.79), and a 43% reduction in ART initiations (IRR 0.57, 95%CI 0.55–0.60). …”
  16. 76

    Heat Shock-Related Protein Responses and Inflammatory Protein Changes Are Associated with Mild Prolonged Hypoglycemia by Abu Saleh Md Moin (6189512)

    Published 2021
    “…We performed a case–control induced hypoglycemia clamp study, maintaining blood glucose at 2.8 mmol/L (50 mg/dL) for 1 h in 17 subjects (T2D (n = 10); controls (n = 7)). …”
  17. 77

    YOLO-DefXpert: An Advanced Defect Detection on PCB Surfaces Using Improved YOLOv11 Algorithm by Prabu Selvam (22330264)

    Published 2025
    “…Compared to the standard YOLOv11 model, the proposed YOLO-DefXpert attained an improvement of 9.3% and 13.2% in mAP50 and mAP95, an 11.25% increase in frames per second, and a 69.85MB decrease in model size. …”
  18. 78
  19. 79

    Performance evaluation of 3D-printed PLA composites doped with WE43 magnesium alloy for bone tissue engineering applications by Sumama Nuthana Kalva (17302906)

    Published 2025
    “…Incorporating magnesium into PLA for 3D printing significantly affected the composites' dimensional stability and formation quality. While a low Mg content (5 %) only slightly impacted the print quality and dimensions, higher Mg concentrations (10 % and 15 %) led to increased weight, rougher surfaces, dimensional shrinkage in height, and overall poorer formation quality. …”
  20. 80

    The promise of tirzepatide: A narrative review of metabolic benefits by Sara Sokary (17337724)

    Published 2025
    “…Moreover, tirzepatide exhibited favorable effects on glycemic control, with notable reductions in HbA1c levels ranging from 20.4 mmol/mol with the 5mg dose to 28.2 mmol/mol with the 15 mg dose, following treatment durations lasting 40–52 weeks. …”